Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Signal Transduction and Targeted Therapy (1)
Nature Communications (1)
Scientific Reports (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (3)

Subject Check one or more subjects to show results from those subjects only.

Biomarkers
Cancer
Chemistry
Diseases
Energy science and technology
Gastroenterology
Genetics
Materials science

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–3 of 3 results

Advanced filters: Author: Lianming Cai Clear advanced filters

Embedding oxophilic rare-earth single atom in platinum nanoclusters for efficient hydrogen electro-oxidation

Exploring enhanced catalysts for alkaline hydrogen oxidation with high catalytic activity and CO tolerance is highly desired yet challenging. Here, the authors report single-atom lanthanide embedded Pt nanoclusters with high activities and durability.

Xiaoning Wang
Yanfu Tong
Wei Xing
ResearchOpen Access24 Jun 2023
Nature Communications

Volume: 14, P: 1-11
Comprehensive characterization of lysosome-dependent cell death reveals prognostic significance and immune landscape in colon adenocarcinoma

Zhenhua Liu
Lianming Cai
Xiangxin Wu
ResearchOpen Access26 Sept 2025
Scientific Reports

Volume: 15, P: 1-19
Finotonlimab (PD-1 inhibitor) plus bevacizumab (bevacizumab biosimilar) as first-tier therapy for late-stage hepatocellular carcinoma: a randomized phase 2/3 trial

Chuanhua Zhao
Yanqiao Zhang
Jianming Xu
ResearchOpen Access06 Aug 2025
Signal Transduction and Targeted Therapy

Volume: 10, P: 1-10